IP Library Granted Patent US 9,504,847
Granted Patent B2
US 9,504,847 · App. 12/964,779 · Granted Nov 29, 2016

Method for performing phototherapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,847
App. No.
12/964,779
Granted
Nov 29, 2016
Kind
B2
Abstract

An improved method for performing phototherapy. The method comprises a step of applying a supplement to the patient before/after light treatment, which produces nitric oxide in the subject biological tissue to be treated. The nitric oxide serves as signaling molecules to cause vasodilatation and increase blood flow and micro-circulation in the biological tissue so as to enhance the effect and reduce the required treatment time of phototherapy.

Claims (12)

1. A method for treating a biological tissue with phototherapy, the method comprising the steps of:

producing a therapeutic light capable of being absorbed by the biological tissue to produce a photochemical reaction in the biological tissue;

providing a supplement capable of being absorbed by the biological tissue to produce nitric oxide (NO) thereof to cause vasodilatation and increased blood flow and micro-circulation in the biological tissue;

applying the therapeutic light to the biological tissue to produce a photochemical reaction in the biological tissue; and

applying the supplement to the biological tissue to cause vasodilatation and increased blood flow and micro-circulation in the biological tissue, wherein said vasodilatation and increased blood flow and micro-circulation facilitates transportation of products of said photochemical reaction.

2. The method of claim 1 , wherein said supplement is applied to the biological tissue before applying the therapeutic light.

3. The method of claim 1 , wherein said supplement is applied to the biological tissue after applying the therapeutic light.

4. The method of claim 1 , wherein said supplement comprises an extract from Morinda Citrifolia (noni) plant.

5. The method of claim 1 , wherein said supplement comprises nitroglycerin.

6. The method of claim 1 , wherein said supplement comprises amyl nitrite.

7. The method of claim 1 , wherein said therapeutic light is produced by a laser light source.

8. The method of claim 1 , wherein said therapeutic light is produced by a light emitting diode (LED) light source.

Assignments (6)
SECURITY INTEREST Recorded Jan 3, 2024
From: LITECURE LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066162/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2020
From: BWT PROPERTY INC.; PRYOR, BRIAN; WANG, SEAN XIAOLU
To: LITECURE LLC
Reel/Frame 054295/0588 →
RELEASE OF SECURITY INTEREST Recorded Mar 26, 2020
From: CITIZENS BANK, N.A.
To: LITECURE LLC
Reel/Frame 052232/0776 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NOTICE OF RECORDDATION NEEDS TO BE CORRECTED APPLICATION 10086211 AND 10238889 TO BE CHANGED TO PATENT NUMBERS PREVIOUSLY RECORDED AT REEL: 050652 FRAME: 0831. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST . Recorded Oct 9, 2019
From: LITECURE LLC
To: CITIZENS BANK, N.A., SUCCESSOR TO RBS CITIZENS, NATIONAL ASSOCIATION
Reel/Frame 050711/0871 →
SECURITY INTEREST Recorded Oct 8, 2019
From: LITECURE LLC
To: CITIZENS BANK, N.A., SUCCESSOR TO RBS CITIZENS, NATIONAL ASSOCIATION
Reel/Frame 050652/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2010
From: PRYOR, BRIAN; WANG, SEAN XIAOLU
To: BWT PROPERTY, INC.
Reel/Frame 025546/0938 →